Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
for Myotonic Dystrophy Type 1 (DM1)
Sites in Rochester +7 more locations
Sponsor: Dyne Therapeutics
Sex: All·Age: 18 - 65
Code: NCT05481879·Phase 1, Phase 2·Recruiting·Listed Aug 2022